FeaturesSignalPricingFounders
Log inGet started free
NV

Novartis Venture Fund

Venture CapitalActive

Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.

Basel, SwitzerlandFounded 2002nvfund.com/
209
Investments
6
Exits
$1.2B
AUM
2.9%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Novartis Venture Fund.

Get started free

Investment Thesis & Strategy

Novartis Venture Fund invests in various stages of companies developing novel therapeutics and platforms. They focus on companies within the therapeutics sector.

Notable Exits

CompanyTypeYearValue / Acquirer
AMAG PharmaceuticalsAcquisition2020$1.4B
Selexys PharmaceuticalsAcquisition2016
Radius HealthIPO2014
SequellaAcquisition2013
ArchemixAcquisition2011
Addex TherapeuticsIPO2007

Frequently Asked Questions

Novartis Venture Fund focuses on Series A, Series B, Series C+ stage investments.

Related Investors